vs
Side-by-side financial comparison of PennyMac Mortgage Investment Trust (PMT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PennyMac Mortgage Investment Trust is the larger business by last-quarter revenue ($93.6M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). PennyMac Mortgage Investment Trust runs the higher net margin — 56.0% vs -38.1%, a 94.0% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -13.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 12.3%).
PennyMac Mortgage Investment Trust is a U.S.-headquartered real estate investment trust specializing in residential mortgage assets. It invests in performing and non-performing mortgage loans, mortgage-backed securities, and credit risk transfer instruments, operating across investment management and mortgage servicing segments in the U.S. housing market.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
PMT vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $93.6M | $83.1M |
| Net Profit | $52.4M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | 38.6% | -4.1% |
| Net Margin | 56.0% | -38.1% |
| Revenue YoY | -13.3% | 20.2% |
| Net Profit YoY | 12.5% | -27.9% |
| EPS (diluted) | $0.49 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $93.6M | $76.4M | ||
| Q3 25 | $99.2M | $83.3M | ||
| Q2 25 | $70.2M | $79.2M | ||
| Q1 25 | $44.5M | $69.2M | ||
| Q4 24 | $107.9M | $68.2M | ||
| Q3 24 | $80.9M | $58.4M | ||
| Q2 24 | $71.2M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $52.4M | $-29.8M | ||
| Q3 25 | $58.3M | $-21.4M | ||
| Q2 25 | $7.5M | $-19.6M | ||
| Q1 25 | $9.7M | $-24.7M | ||
| Q4 24 | $46.5M | $-18.9M | ||
| Q3 24 | $41.4M | $-21.0M | ||
| Q2 24 | $25.4M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 38.6% | -40.6% | ||
| Q3 25 | 47.4% | -27.8% | ||
| Q2 25 | 24.2% | -28.0% | ||
| Q1 25 | -14.2% | -39.7% | ||
| Q4 24 | 51.1% | -28.9% | ||
| Q3 24 | 32.8% | -38.4% | ||
| Q2 24 | 40.2% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 56.0% | -39.1% | ||
| Q3 25 | 58.7% | -25.7% | ||
| Q2 25 | 10.7% | -24.7% | ||
| Q1 25 | 21.8% | -35.8% | ||
| Q4 24 | 43.1% | -27.6% | ||
| Q3 24 | 51.2% | -35.9% | ||
| Q2 24 | 35.7% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.49 | $-0.54 | ||
| Q3 25 | $0.55 | $-0.38 | ||
| Q2 25 | $-0.04 | $-0.35 | ||
| Q1 25 | $-0.01 | $-0.45 | ||
| Q4 24 | $0.45 | $-0.34 | ||
| Q3 24 | $0.36 | $-0.40 | ||
| Q2 24 | $0.17 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $190.5M | $245.6M |
| Total DebtLower is stronger | $1.1B | $51.7M |
| Stockholders' EquityBook value | $1.9B | $347.7M |
| Total Assets | $21.3B | $487.1M |
| Debt / EquityLower = less leverage | 0.58× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $190.5M | $286.5M | ||
| Q3 25 | $181.0M | $294.3M | ||
| Q2 25 | $108.6M | $302.7M | ||
| Q1 25 | $204.2M | $316.2M | ||
| Q4 24 | $103.2M | $333.7M | ||
| Q3 24 | $102.8M | $196.8M | ||
| Q2 24 | $336.3M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $1.1B | $51.6M | ||
| Q3 25 | $299.0M | $51.6M | ||
| Q2 25 | $1.2B | $51.5M | ||
| Q1 25 | $968.4M | $51.5M | ||
| Q4 24 | $1.0B | $51.5M | ||
| Q3 24 | $5.2B | $51.4M | ||
| Q2 24 | $5.4B | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $1.9B | $365.9M | ||
| Q3 25 | $1.9B | $380.3M | ||
| Q2 25 | $1.9B | $385.8M | ||
| Q1 25 | $1.9B | $389.2M | ||
| Q4 24 | $1.9B | $402.2M | ||
| Q3 24 | $1.9B | $241.2M | ||
| Q2 24 | $1.9B | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $21.3B | $508.1M | ||
| Q3 25 | $18.5B | $511.5M | ||
| Q2 25 | $16.8B | $513.1M | ||
| Q1 25 | $14.9B | $519.4M | ||
| Q4 24 | $14.4B | $534.0M | ||
| Q3 24 | $13.1B | $374.1M | ||
| Q2 24 | $12.1B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.58× | 0.14× | ||
| Q3 25 | 0.16× | 0.14× | ||
| Q2 25 | 0.65× | 0.13× | ||
| Q1 25 | 0.51× | 0.13× | ||
| Q4 24 | 0.52× | 0.13× | ||
| Q3 24 | 2.70× | 0.21× | ||
| Q2 24 | 2.76× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.2B | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -137.76× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-7.2B | $-10.3M | ||
| Q3 25 | $-1.3B | $-6.6M | ||
| Q2 25 | $-2.0B | $-15.0M | ||
| Q1 25 | $-594.3M | $-17.0M | ||
| Q4 24 | $-2.7B | $-32.4M | ||
| Q3 24 | $-983.8M | $-18.8M | ||
| Q2 24 | $243.8M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | -137.76× | — | ||
| Q3 25 | -22.26× | — | ||
| Q2 25 | -267.53× | — | ||
| Q1 25 | -61.39× | — | ||
| Q4 24 | -58.08× | — | ||
| Q3 24 | -23.76× | — | ||
| Q2 24 | 9.59× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PMT
| Other | $55.0M | 59% |
| Interest Rate Sensitive Strategies | $31.4M | 34% |
| Correspondent Production | $7.2M | 8% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
